More recently, KDs have been suggested as a promising therapeutic intervention for reversing metabolic sequalae and endocrinopathies, specifically in women [24], with pilot studies supporting the evidence for improvements in glycemic control, insulin sensitivity, cholesterol profiles, hormonal profiles and circulating androgens [12, 25]. The gene discussed is INS; the disease is endocrine system disorder.